ORAL PHARMACEUTICAL FORM BASED ON AT LEAST ONE ACTIVE INGREDIENT WHOSE SOLUBILITY VARIES IN ACCORDANCE WITH THE CONDITIONS OF GASTRIC PH
FR2885526A1
ORAL MEDICINE BASED ON PROTON PUMP INHIBITOR
FR2884145A1
Use of a controlled release losartan oral dosage form, to decrease the inter individual gap of standard deviation of maximum concentration of the losartan, independent of administration of losartan before or after the meals
FR2882260A1
MULTIMICROPARTICULAR ORAL PHARMACEUTICAL FORM WITH MODIFIED RELEASE OF ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
FR2882259A1
Use of a controlled release losartan oral dosage form, to decrease the inter individual gap of standard deviation of maximum concentration of the losartan, independent of administration of losartan before or after the meals
FR2881652A1
MICROPARTICULAR ORAL PHARMACEUTICAL FORM ANTI-MEASURING
FR2881140A1
COPOLYHYDROXYALKYLGLUTAMINES FUNCTIONALIZED BY HYDROPHOBIC GROUPS AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS
FR2878158A1
ORAL PHARMACEUTICAL FORM, SOLID MICROPARTICULAR DESIGNED TO PREVENT MEASUREMENT
FR2878159A1
ORAL MEDICATION WITH MODIFIED RELEASE OF AT LEAST ONE ACTIVE PRINCIPLE IN MULTIMICROCAPSULAR FORM
FR2878161A1
ORAL MEDICINE FORM, SOLID AND DESIGNED TO AVOID MEASUREMENT
FR2873704A1
POLYAMINOACIDES FUNCTIONALIZED BY HYDROPHOBIC GRAFTS CARRYING AN ANIONIC CHARGE AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS
FR2873703A1
BRANCHED POLYAMINOACIDES FUNCTIONALIZED BY HYDROPHOBIC GROUPS AND THEIR PARTICULARLY THERAPEUTIC APPLICATIONS
FR2873040A1
COLLOIDAL FORMULATION OF LONG-ACTING INSULIN AND ITS PREPARATION
